New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors
- PMID: 20196805
- PMCID: PMC3020328
- DOI: 10.1111/j.1365-2893.2010.01280.x
New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors
Abstract
Recently, we studied hepatitis C virus (HCV) sera-prevalence among 559 890 first-time volunteer blood donors in China. From randomly selected 450 anti-HCV positive donors, we detected HCV RNA in 270 donors. In this study, we amplified HCV E1 and/or NS5B sequences from 236 of these donors followed by DNA sequencing and phylogenetic analysis. The results indicate new trends of HCV infection in China. The HCV genotype distribution differed according to the donors' region of origin. Among donors from Guangdong province, we detected subtypes 6a, 1b, 3a, 3b, 2a, and 1a at frequencies of 49.7%, 31.0%, 7.6%, 5.5%, 4.1%, and 2.1%, respectively. Among donors from outside Guangdong, we detected 1b, 2a, 6a, 3b, 3a, 6e, and 6n at frequencies 57.1%, 13.2%, 11.0%, 9.9%, 4.4%, 2.2%, and 2.2%, respectively. Although we found no significant differences among regions in age or gender, subtype 6a was more common (P < 0.001) in donors from Guangdong than those from elsewhere, whilst subtypes 1b (P < 0.02) and 2a (P < 0.001) were more frequent outside Guangdong. Disregarding origins, the male/female ratio was higher for subtype 6a-infected donors (P < 0.05) than for subtype 1b donors, whilst the mean age of subtype 2a donors was 8-10 years older (P < 0.05) than that for all other subtypes. Detailed phylogenetic analysis of our sequence data provides further insight into the transmission of HCV within China, and between China and other countries. The predominance of HCV 6a among blood donors in Guangdong is striking and mandates studies into risk factors for its acquisition.
Figures




Similar articles
-
Migration patterns of hepatitis C virus in China characterized for five major subtypes based on samples from 411 volunteer blood donors from 17 provinces and municipalities.J Virol. 2014 Jul;88(13):7120-9. doi: 10.1128/JVI.00414-14. Epub 2014 Apr 9. J Virol. 2014. PMID: 24719413 Free PMC article.
-
Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004-2007 and 2008-2011.Arch Virol. 2014 Dec;159(12):3231-7. doi: 10.1007/s00705-014-2185-1. Epub 2014 Aug 2. Arch Virol. 2014. PMID: 25085624 Free PMC article.
-
An increased diversity of HCV isolates were characterized among 393 patients with liver disease in China representing six genotypes, 12 subtypes, and two novel genotype 6 variants.J Clin Virol. 2013 Aug;57(4):311-7. doi: 10.1016/j.jcv.2013.04.013. Epub 2013 May 21. J Clin Virol. 2013. PMID: 23706765 Free PMC article.
-
Subtype distribution of hepatitis C virus in Jiangsu, China.J Med Virol. 2016 Mar;88(3):498-505. doi: 10.1002/jmv.24356. Epub 2015 Aug 31. J Med Virol. 2016. PMID: 26288243
-
Genetic history of hepatitis C virus genotype 6 in Taiwan.J Formos Med Assoc. 2024 Sep;123(9):926-933. doi: 10.1016/j.jfma.2023.10.013. Epub 2023 Nov 22. J Formos Med Assoc. 2024. PMID: 37996321 Review.
Cited by
-
The current hepatitis C virus prevalence in China may have resulted mainly from an officially encouraged plasma campaign in the 1990s: a coalescence inference with genetic sequences.J Virol. 2013 Nov;87(22):12041-50. doi: 10.1128/JVI.01773-13. Epub 2013 Aug 28. J Virol. 2013. PMID: 23986603 Free PMC article.
-
Distribution and changes in hepatitis C virus genotype in China from 2010 to 2020.World J Clin Cases. 2022 May 16;10(14):4480-4493. doi: 10.12998/wjcc.v10.i14.4480. World J Clin Cases. 2022. PMID: 35663077 Free PMC article.
-
24 versus 48 Weeks of Peginterferon Plus Ribavirin in Hepatitis C Virus Genotype 6 Chronically Infected Patients with a Rapid Virological Response: A Non-Inferiority Randomized Controlled Trial.PLoS One. 2015 Oct 28;10(10):e0140853. doi: 10.1371/journal.pone.0140853. eCollection 2015. PLoS One. 2015. PMID: 26509605 Free PMC article. Clinical Trial.
-
Changing Epidemiology of Hepatitis C Virus Genotype among Patients with Human Immunodeficiency Virus/Hepatitis C Virus Co-Infection in China.PLoS One. 2016 Sep 7;11(9):e0161844. doi: 10.1371/journal.pone.0161844. eCollection 2016. PLoS One. 2016. PMID: 27603929 Free PMC article.
-
Anti-HCV reactive volunteer blood donors distribution character and genotypes switch in Xi'an, China.Virol J. 2010 Aug 10;7:186. doi: 10.1186/1743-422X-7-186. Virol J. 2010. PMID: 20698949 Free PMC article.
References
-
- World Health Organization Hepatitis C global prevalence. Wkly Epidemiol Rec. 1999;74:425–427. - PubMed
-
- World Health Organization Hepatitis C. Wkly Epidemiol Rec. 1997;72:65–69. - PubMed
-
- Aymard JP, Botte C, Contal P, Janot C, Treiff F. Seroprevalence of hepatitis C-antibodies among blood donors: study of second generation ELISA & RIBA tests and surrogate markers. Pathol Biol (Paris) 1993;41:149–153. - PubMed
-
- Shakil AO, Conry-Cantilena C, Alter HJ, et al. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group. Ann Intern Med. 1995;123:330–337. - PubMed
-
- Panigrahi AK, Panda SK, Dixit RK, et al. Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver disease. J Med Virol. 1997;51:167–174. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases